Home » Topics » BioWorld Science

BioWorld Science
RSS

Monoclonal antibody fragments as immunosuppressants

July 26, 1996

Vistide available in U.S. as CMV treatment in AIDS patients

July 26, 1996

COX-2 inhibitors described to treat inflammation

July 26, 1996

rBCG-V3JI: Ajinomoto's vector-based vaccine

July 26, 1996

Immunogenic oligomeric HIV-1 gp160 vaccine described

July 26, 1996

Rz9456: Potential hematopoietic stem cell therapy for AIDS

July 26, 1996

Cyanovirin-N selected for high priority development by the National Cancer Institute

July 26, 1996

CHAM3 induces clinical and biological improvement in HIV patients

July 26, 1996

ZY-1 demonstrates therapeutic promise in HIV patients

July 26, 1996

TAR-PAK-140: University of Alberta's anti-HIV vector

July 26, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
ASH 2025: Ianalumab data offer break from chronic ITP therapy
BioWorld
Novartis AG’s monoclonal antibody, ianalumab (VAY-736), when added to standard-of-care eltrombopag, extended disease control of primary immune thrombocytopenia...